The TransMedTech Institute will collaborate with MEDTEQ with the aim of bringing new medical technologies into the Canadian health system by simplifying and accelerating the steps taken by their researchers and the project selection process.
The two organisations are joining forces so they can co-manage collaborative research and innovation projects eligible for funding from both organisations. This co-management will be made possible by the sharing of expertise, infrastructure and human resources. MEDTEQ’s scientific committee will evaluate joint projects as well as projects eligible for TransMedTech funding only.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
TransMedTech Institute scientific director Professor Carl-Éric Aubin said: “Our combined skills and expertise will undoubtedly create a value chain, as well as bridges to industry and enable medical technology R&D projects that will have a real impact on society to be implemented more quickly and easily.”
MEDTEQ president and CEO Diane Côté added: “The complementarity of TransMedTech’s research skills, and MEDTEQ’s expertise in establishing the industrial sector in medical technology innovation projects and commercialisation, is certainly a winning formula for research teams, industrial partners, healthcare centres and ultimately the patient.”
The agreement also confirms the implementation of a project co-financing system as TransMedTech and MEDTEQ have developed complementary skills in this field. Their alliance will enable collaborative research and innovation projects eligible for funding from both organisations to be funded first by TransMedTech, and then to access MEDTEQ funding once they have reached a certain level of technological maturity.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
